Cargando…

Radiation therapy for epithelial ovarian cancer brain metastases: clinical outcomes and predictors of survival

BACKGROUND: Brain metastases (BM) and leptomeningeal disease (LMD) are uncommon in epithelial ovarian cancer (EOC). We investigate the outcomes of modern radiation therapy (RT) as a primary treatment modality in patients with EOC BM and LMD. METHODS: We evaluated 60 patients with EOC treated at our...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teckie, Sewit, Makker, Vicky, Tabar, Viviane, Alektiar, Kaled, Aghajanian, Carol, Hensley, Martee, Beal, Kathryn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608316/ https://www.ncbi.nlm.nih.gov/pubmed/23414446 http://dx.doi.org/10.1186/1748-717X-8-36

Ejemplares similares

The Resilience of Radiation Oncology in the COVID Era and Beyond
por: Teckie, Sewit, et al.
Publicado: (2020)

Predictors of survival in patients with MALT lymphoma: a retrospective, case-control study
por: Qi, Shunan, et al.
Publicado: (2022)

Guidelines to Reduce Hospitalization Rates for Patients Receiving Curative-Intent Radiation Therapy During the COVID-19 Pandemic: Report From a Multicenter New York Area Institution
por: Chen, William C., et al.
Publicado: (2020)

SURG-03. The effect of surgery on radiation necrosis in irradiated brain metastases: extent of resection and long-term clinical and radiographic outcomes
por: Newman, William, et al.
Publicado: (2021)

Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade
por: Boland, Julia L., et al.
Publicado: (2018)

Implementation of Telehealth in Radiation Oncology: Rapid Integration During COVID-19 and Its Future Role in Our Practice
por: Goenka, Anuj, et al.
Publicado: (2020)

Retreatment with carboplatin and paclitaxel for recurrent endometrial cancer: A retrospective study of the Memorial Sloan Kettering Cancer Center experience
por: Rubinstein, Maria, et al.
Publicado: (2019)

69. PERMANENT INTRACAVITARY Cs131 BRACHYTHERAPY FOR PREVIOUSLY-IRRADIATED RECURRENT BRAIN METASTASES: INITIAL CLINICAL AND RADIATION SAFETY EXPERIENCE
por: Moss, Nelson S, et al.
Publicado: (2020)

TRLS-07. Intracavitary carrier-embedded Cs131 brachytherapy for recurrent brain metastases: A randomized phase II study
por: Moss, Nelson S, et al.
Publicado: (2021)

Combined immunotherapy and radiation for treatment of mucosal melanomas of the lower genital tract()
por: Schiavone, Maria B., et al.
Publicado: (2016)

Brain metastasis in advanced serous borderline tumor of the ovary: A case presentation()
por: Martin, Madhuri, et al.
Publicado: (2017)

Small cell neuroendocrine carcinoma of the cervix: Analysis of prognostic factors and patterns of metastasis
por: Gordhandas, Sushmita, et al.
Publicado: (2022)

MLTI-05. Adjuvant re-irradiation improves local control of surgically resected recurrent brain metastases
por: Wilcox, Jessica, et al.
Publicado: (2021)

LOCL-15 PERMANENT CARRIER-EMBEDDED CESIUM-131 BRACHYTHERAPY FOR THE SALVAGE TREATMENT OF PREVIOUSLY IRRADIATED, RECURRENT BRAIN METASTASES
por: Imber, Brandon S, et al.
Publicado: (2022)

Sarcomatous Change of Cerebellopontine Angle Ependymoma Following Radiosurgery: A Case Report
por: Dadario, Nicholas B, et al.
Publicado: (2022)

Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases
por: Imber, Brandon S., et al.
Publicado: (2022)

Early-Stage epithelial ovarian cancer: Predictors of survival
por: Upadhyay, Avinash, et al.
Publicado: (2022)

Outcomes Following Early Postoperative Adjuvant Radiosurgery for Brain Metastases
por: Bander, Evan D., et al.
Publicado: (2023)

Quality of Life Outcomes Following Organ-Sparing SBRT in Previously Irradiated Recurrent Head and Neck Cancer
por: Gogineni, Emile, et al.
Publicado: (2019)

Skin metastases in epithelial ovarian and fallopian tube carcinoma
por: Otsuka, Isao, et al.
Publicado: (2017)

Treatment of liver metastases in patients with epithelial ovarian cancer
por: Deng, Hao, et al.
Publicado: (2021)

The ABR 2021 Radiation Oncology Remote Examinations: Development, Administration, and Implications for the Future
por: Wallner, Paul E., et al.
Publicado: (2022)

A Mobile Patient-Facing App for Tracking Patient-Reported Outcomes in Head and Neck Cancer Survivors: Single-Arm Feasibility Study
por: Teckie, Sewit, et al.
Publicado: (2021)

Stereotactic radiotherapy in epithelial ovarian cancer brain metastases patients
por: Celejewska, Agata, et al.
Publicado: (2014)

50. RISK OF TRACT RECURRENCE WITH STEREOTACTIC BIOPSY OF BRAIN METASTASES: AN 18-YEAR CANCER CENTER EXPERIENCE
por: Carnevale, Joseph, et al.
Publicado: (2020)

The association between lymph node metastases and long-term survival in patients with epithelial ovarian cancer
por: Lepinay, Katarzyna, et al.
Publicado: (2020)

Survival of patients treated with radiation therapy for anaplastic astrocytoma
por: Barker, Christopher A., et al.
Publicado: (2014)

Platinum sensitivity and CD133 expression as risk and prognostic predictors of central nervous system metastases in patients with epithelial ovarian cancer
por: Liu, Bo-lin, et al.
Publicado: (2014)

PDCD6 is an independent predictor of progression free survival in epithelial ovarian cancer
por: Su, Dan, et al.
Publicado: (2012)

Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient
por: Jiménez-Sánchez, Alejandro, et al.
Publicado: (2017)

Molecular Mechanisms Regulating Organ-Specific Metastases in Epithelial Ovarian Carcinoma
por: Barbolina, Maria V.
Publicado: (2018)

Are Epithelial Ovarian Cancers of the Mesenchymal Subtype Actually Intraperitoneal Metastases to the Ovary?
por: Hu, Ye, et al.
Publicado: (2020)

Proton radiotherapy for recurrent or metastatic sarcoma with palliative quad shot
por: Lee, Anna, et al.
Publicado: (2021)

Brain metastases in patients with low-grade endometrial carcinoma
por: Cybulska, Paulina, et al.
Publicado: (2018)

C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma
por: Mahner, S, et al.
Publicado: (2008)

Predictors of Survival Outcomes After Primary Treatment of Epithelial Ovarian Cancer in Lagos, Nigeria
por: Okunade, Kehinde Sharafadeen, et al.
Publicado: (2021)

A Syngeneic Mouse Model of Epithelial Ovarian Cancer Port Site Metastases
por: Wilkinson-Ryan, Ivy, et al.
Publicado: (2018)

Novel Molecular Targets for Tumor-Specific Imaging of Epithelial Ovarian Cancer Metastases
por: de Muynck, Lysanne D. A. N., et al.
Publicado: (2020)

Predictors of early mortality risk in patients with epithelial ovarian cancer
por: Okunade, Kehinde S., et al.
Publicado: (2022)

Carbonyl reductase as a significant predictor of survival and lymph node metastasis in epithelial ovarian cancer
por: Umemoto, M, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_cegl9kng4u2j7bv3glasd9a52f